| Article
Survivors of a terror attack are at elevated risk for frequent migraine and tension headache, suggests the conclusions from a recent study in Norway. The investigation centered on the teenage survivors of the 2011 incident at a summer youth camp on Utoya Island in which a gunman killed 69 campers...
| Article
Results of a recent phase III clinical trial confirm the efficacy and safety of a novel antibody therapy in reducing the number of days of headache experienced by chronic migraine sufferers. The findings from the HALO CM trial, resorted by researchers from Thomas Jefferson University Hospital,...
| Article
Results from a small randomized trial suggest that botulinum toxin injections may be an effective alternative therapy for migraine headache in children and teens that is refractory to standard treatment approaches. Currently, botulinum toxin is FDA approved for treating migraine in adults only, and...
| Article
Findings from a retrospective study of patients with intractable migraine headache suggest that ketamine may be an effective treatment option. The review of data for 61 patients whose migraine had failed other treatments found that almost 75% reported reduced headache intensity following a 3- to 7...
| Article
While seeking to uncover evidence of racial disparities in the treatment of migraine, researchers at University of Michigan Medical School documented an entirely different problem: overuse of opioids as migraine therapy across all racial groups. Based on the knowledge that African-Americans are at...
| Article
Researchers at Beth Israel Deaconess Medical Center, Boston, have reported that exposure to light can cause migraine sufferers to experience changes in mood and negatively impact a range of physiological parameters including heart rate, breathing, fatigue, nausea and congestion. The findings advance...
| Article
A meta-analysis led by B. Lee Peterlin, DO, at Johns Hopkins University School of Medicine concludes that both excessive weight and underweight conditions are associated with increased risk for migraine headache. The analysis examined 12 studies of body mass index (BMI) and migraine incidence...
| Article
The connection between migraine headache and dopamine levels has been a poorly understood area of therapy and research, although patients undergoing a migraine attack may often be administered dopamine antagonists to smooth fluctuations in dopamine levels and lessen the headache pain. New research...
| Article
Conclusions from a preliminary study suggest that a recently developed wireless electrical stimulation device provides relief of pain from migraine that is comparable to that achieved by triptan medications. The device was developed by Theranica, Ltd., an Israeli-based maker of neuromodulation...
| Video
Evidence based biobehavioral therapies, including cognitive behavioral therapy (CBT) and biobehavioral training are indicated for a variety of chronic pain conditions, including fibromyalgia and migraine headache. Dr. Buse, a psychologist, researcher and professor of medicine, outlines what primary...